Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-08184 · Session 2

Further to the answer to question S2W-7671 by Malcolm Chisholm on 5 May 2004, whether it will provide further details of the scientific res…

Answered Asked by Carolyn Leckie SSP Lodged 12 May 2004

The question

To ask the Scottish Executive, further to the answer to question S2W-7671 by Malcolm Chisholm on 5 May 2004, whether it will provide further details of the scientific research and evidence to support the statement that the DTwP-Hib vaccine has been demonstrated to give more effective protection against whooping cough (pertussis) than the DTaP-Hib alternative, specifying the author, journal of publication and where the research was conducted.

The answer

Answered by Malcolm Chisholm on 25 May 2004 · 13 days after it was lodged, on time

The reasons for preferring highquality DTwP products over DTaP vaccine for primary immunisation are fully exploredin the paper Overview of Recent Clinical Trials of Acellular Pertussis Vaccines(Miller E) published in Biologicals (1999) Vol. 27; 79-86. This paper, whichis a review of trials conducted in Sweden, Italy, Senegal and Germany, identified that “with the exception of the five componentvaccine, acellular vaccines are less efficacious than a good whole cell vaccine”.At present, five component acellular vaccines are not available in the UK.

In the Official Report

No contribution in the Official Report cites S2W-08184 by reference.